These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6705277)

  • 1. Hepatitis B vaccine: randomized trial of immunogenicity in hemodialysis patients.
    Benhamou E; Courouce AM; Jungers P; Laplanche A; Degos F; Brangier J; Crosnier J
    Clin Nephrol; 1984 Mar; 21(3):143-7. PubMed ID: 6705277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vaccination schedule and dialysis on hepatitis B vaccination response in uraemic patients.
    Bommer J; Ritz E; Andrassy K; Bommer G; Deinhardt F; Jilg W; Darai G
    Proc Eur Dial Transplant Assoc; 1983; 20():161-8. PubMed ID: 6657651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
    Lelie PN; Reesink HW; de Jong-van Manen ST; Dees PJ; Reerink-Brongers EE
    Arch Intern Med; 1985 Feb; 145(2):305-9. PubMed ID: 3977491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of immune response to hepatitis B vaccine in Thai blood donors.
    Nuchprayoon C; O-Charoen RO; Vaivanijkul J; Apirakyothin T; Akkawat R; Chumnijarakij T
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):17-21. PubMed ID: 1387972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination in patients with chronic hepatitis C.
    Lee SD; Chan CY; Yu MI; Lu RH; Chang FY; Lo KJ
    J Med Virol; 1999 Dec; 59(4):463-8. PubMed ID: 10534727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B vaccination].
    Descoeudres C
    Schweiz Med Wochenschr; 1984 Apr; 114(15):498-505. PubMed ID: 6729415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
    Liu YL; Kao MT; Huang CC
    Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U; Thomas PP; Shastry JC; Jacob CK
    J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.